FDA approves IV formulation of aprepitant for CINVNovember 10, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated Issues
Ibrutinib sustains efficacy in CLL at 4-year follow-upNovember 7, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Intervention improves well-being in AYAs with cancerNovember 7, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated Issues
Cancer drug costs increasing despite competitionNovember 6, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyAMLALLNon-Hodgkin Lymphoma
Cancer patients prefer computer-free interactionsNovember 3, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
FDA approves drug to treat rel/ref MCLNovember 1, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
FDA approves IV formulation of drug for CINVOctober 27, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated Issues
CCSs more likely to stay at jobs to keep health insuranceOctober 25, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Drug receives breakthrough designation for DLBCLOctober 25, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
High symptom burden in advanced cancer patientsOctober 24, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
EMA recommends orphan designation for G100 to treat FLOctober 24, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
New assay may aid diagnosis, treatment of DLBCLOctober 23, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
What we don’t know about BIA-ALCLOctober 20, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
CAR T-cell therapy approved to treat lymphomasOctober 19, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Gel shows promise for treating early stage MFOctober 17, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma